Massachusetts Financial Services’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.27M | Buy |
58,688
+725
| +1% | +$15.6K | ﹤0.01% | 798 |
|
|
2025
Q1 | $963K | Sell |
57,963
-1,320
| -2% | -$21.9K | ﹤0.01% | 810 |
|
|
2024
Q4 | $1.09M | Sell |
59,283
-1,768
| -3% | -$32.4K | ﹤0.01% | 812 |
|
|
2024
Q3 | $939K | Sell |
61,051
-1,479
| -2% | -$22.7K | ﹤0.01% | 799 |
|
|
2024
Q2 | $1.02M | Buy |
62,530
+2,100
| +3% | +$34.1K | ﹤0.01% | 797 |
|
|
2024
Q1 | $1.12M | Sell |
60,430
-134
| -0.2% | -$2.48K | ﹤0.01% | 777 |
|
|
2023
Q4 | $1.9M | Buy |
+60,564
| New | +$1.9M | ﹤0.01% | 726 |
|
|
2018
Q2 | – | Sell |
-248,233
| Closed | -$5.58M | – | 839 |
|
|
2018
Q1 | $5.58M | Buy |
248,233
+66,283
| +36% | +$1.49M | ﹤0.01% | 658 |
|
|
2017
Q4 | $5.48M | Buy |
181,950
+2,414
| +1% | +$72.7K | ﹤0.01% | 657 |
|
|
2017
Q3 | $6.76M | Buy |
179,536
+1,096
| +0.6% | +$41.3K | ﹤0.01% | 641 |
|
|
2017
Q2 | $4.98M | Sell |
178,440
-35
| -0% | -$976 | ﹤0.01% | 668 |
|
|
2017
Q1 | $6.14M | Sell |
178,475
-266
| -0.1% | -$9.15K | ﹤0.01% | 633 |
|
|
2016
Q4 | $5.16M | Sell |
178,741
-429
| -0.2% | -$12.4K | ﹤0.01% | 655 |
|
|
2016
Q3 | $5.7M | Sell |
179,170
-59,517
| -25% | -$1.89M | ﹤0.01% | 633 |
|
|
2016
Q2 | $7.75M | Buy |
238,687
+42,720
| +22% | +$1.39M | ﹤0.01% | 598 |
|
|
2016
Q1 | $5.48M | Buy |
+195,967
| New | +$5.48M | ﹤0.01% | 631 |
|